Quantum Biopharma (QNTM) Divestments (2019 - 2024)
Quantum Biopharma (QNTM) posted Divestments of $2.7 million for Q4 2024, up 179.32% sequentially from -$3.5 million in Q3 2024, and up 919.15% YoY from $269579.0 in Q1 2024.
Quantum Biopharma (QNTM) Divestments (2019 - 2024) Analysis & Trends
Quantum Biopharma has reported Divestments for 6 years, with the latest figure at $2.7 million in Q4 2024.
- Quarterly Divestments rose 919.15% year-over-year to $2.7 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$0.0 (up 100.0% YoY) and the FY2022 annual result came in at $12.7 million, changed N/A from the prior year.
- Divestments climbed to $2.7 million in Q4 2024 per QNTM's latest filing, from -$3.5 million in the prior quarter.
- Over five years, Divestments peaked at $4.3 million in Q1 2020 and troughed at -$6.3 million in Q3 2020.
- A 5-year average of -$56144.5 and a median of $123719.5 in 2023 frame the typical range for Divestments.
- The sharpest annual moves came in 2020 and 2024: Divestments soared 1297.81% in 2020, then tumbled 1184.78% in 2024.
- Over 5 years, Divestments stood at -$6.3 million in 2020, then jumped by 84.18% to -$1.0 million in 2021, then soared by 89.34% to -$106586.0 in 2022, then soared by 352.92% to $269579.0 in 2023, then jumped by 919.15% to $2.7 million in 2024.
- According to Business Quant data, Divestments over the past three periods registered $2.7 million, -$3.5 million, and $738222.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.81 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.52 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.30 Bn | 60.11 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.77 Bn | 28.46 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.16 Bn | 26.32 Bn | - | -13.21 Mn |
| 10 | Quantum Biopharma | 15.58 Mn | 11.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.75 Mn |
| Sep 30, 2024 | -3.46 Mn |
| Jun 30, 2024 | 738,222.00 |
| Mar 31, 2024 | -22,140.00 |
| Dec 31, 2023 | 269,579.00 |
| Sep 30, 2023 | -269,579.00 |
| Mar 31, 2022 | -106,586.00 |
| Jun 30, 2021 | -1.00 Mn |
| Mar 31, 2021 | 500,000.00 |
| Sep 30, 2020 | -6.32 Mn |
| Jun 30, 2020 | 1.91 Mn |
| Mar 31, 2020 | 4.35 Mn |
| Mar 31, 2019 | -362,758.09 |